Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

33 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 20 mg sildenafil citrate by mouth Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
2 5% sildenafil cream Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 50 💬
3 Access program - sildenafil citrate, viagra, revatio Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
4 Bosentan and sildenafil Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
5 Duo-therapy with sildenafil + bosentan Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
6 Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) Bosentan 6件: D01227, D02008, D02229, D07538, D08514, D10135 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
7 G04be03- sildenafil - sildenafil (citrato) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
8 Mono-therapy with sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
9 Oral sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
10 Other: standard of care sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 2件: 90, 301 💬
11 Sildenafil Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
12 Sildenafil (50 mg) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 85 💬
13 Sildenafil (acute-1 hour) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 299 💬
14 Sildenafil (as citrate) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
15 Sildenafil (revatio) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
16 Sildenafil (revatio) 20 mg tid Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
17 Sildenafil (subchronic-4 weeks) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 299 💬
18 Sildenafil 20 mg tablets Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 278 💬
19 Sildenafil 20mg Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 2件: 51, 86 💬
20 Sildenafil 20mg and bosentan 62.5mg Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 51, 86 💬
21 Sildenafil 40mg oral capsule Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 299 💬
22 Sildenafil and losartan Losartan 4件: D00357, D02229, D08146, D08514 💬 2件: AGTR1, PDE5A 💬 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 85 💬
23 Sildenafil by injection Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 210 💬
24 Sildenafil citrate Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 4件: 51, 85, 86, 225 💬
25 Sildenafil citrate (uk-92,480) Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
26 Sildenafil filmtabletten Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
27 Sildenafil singly or in association with bosentan Bosentan 4件: D01227, D02229, D07538, D08514 💬 3件: EDNRA, EDNRB, PDE5A 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
28 Sildenafil therapy Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 51 💬
29 Sildenafil25 mg - - - - 1件: 17 💬
30 Sildenafilo Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
31 Sitaxsentan and sildenafil Sildenafil 3件: D02229, D07171, D08514 💬 2件: EDNRA, PDE5A 💬 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
32 Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth Dextrose, unspecified form 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
33 Tadalafil and sildenafil Sildenafil 3件: D02008, D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 113 💬

先頭へ